April 20th, 2007, by David Pascoe | tetracyclines
This article, just published is adding to body of research of the anti-inflammatory actions of the tetracycline family. Recent related studies have been undertaken during the development of low dose doxycycline, for eg. oracea. So far this abstract isn’t teasing us with anything new. A similarly titled paper from 2006, Tetracyclines: their non-antibiotic properties also addressed this topic. Anti-Inflammatory Activity …
November 16th, 2006, by David Pascoe | tetracyclines
In a recently published paper (previously mentioned only via the Abstract – Tetracyclines: their non-antibiotic properties ) we can read some more about how the regular, non-antibiotic (low dose) and chemically modified tetracycline analogues target rosacea.
Tetracyclines: nonantibiotic properties and their clinical implications., Journal American Academy of Dermatology, 2006 Feb;54(2):258-65., Allen N. Sapadin MD, and Raul Fleischmajer MD.
Mechanisms of action of tetracycline and tetracycline …
November 14th, 2006, by David Pascoe | tetracyclines
Rosacea News first wrote about Col-3 in August 2005 – COL-3 new tetracycline derivative being studied. We’ve also mentioned that COL-3 was renamed to Incyclinide – Incyclinide (CollaGenex) gets NIH Funding and Incyclinide phase 2 for acne.
In a recently published paper (previously mentioned only via the Abstract – Tetracyclines: their non-antibiotic properties ) we can read some more information about Incyclinide …
October 4th, 2006, by David Pascoe | oracea, rosacea cause, tetracyclines
Collagenex has launched a swish looking consumer and practitioner web site at www.rosaceatoday.com. Collagenex are indirectly using this site to promote their `new’ treatment Oracea as an effective way to treat rosacea. The site is supporting the idea that rosacea is a chronic inflammatory disease.
Many rosacea sufferers are helped by taking systemic antibiotics. This benefit does not lead to the conclusion that rosacea is …
March 5th, 2006, by David Pascoe | macrolides, tetracyclines
Acne rosacea: An open comparative trial of azithromycin versus oxytetracycline therapy: Study of 50 patientsBakar Bouadjar, PhD, CHU of BEO, Algiers, AlgeriaBackground: Azithromycin has been used successfully to treat acne vulgaris and its use for the treatment of rosacea has been evaluated only once in an open study. Objectives: The goal of the study was to compare the …
|
|
|
|
|
|
|
|
 |